The quick growth and development have provoked the improvements in pen needles with an aim to reduce the pain, give comfort, and overall to lessen the needle used injuries. These devices are advanced devices and best in class and give a superior optional delivery method in contrast with syringes and vials. Patients with diabetes normally utilize injectable pen devices, which helps in simple medication delivery. Obesity is a one of the reason for diabetes. Obese individuals frequently experience the ill effects of sort 2 diabetes, which makes them one of the most elevated income supporters of the target market. So people with type 2 diabetics are more or less the target patients who use most of the companies producing pen needles.
How Big is the Global Pen Needles Market?
The Global Pen Needles Market is expected to exceed more than US$ 5.70 Billion by 2028 at a CAGR of 13% in the given forecast period.
The major driving factors of Global Pen Needles Market are as follows:
The restraining factors of Global Pen Needles Market are as follows:
The Global Pen Needles Market is segmented on the lines of its product, length, therapy and regional. Based on product segmentation it covers standard pen needles, safety pen needles. Based on length segmentation it covers 4mm, 5mm, 6mm, 8mm, 10mm, 12mm. Based on therapy segmentation it covers insulin, glucagon-like-peptide-1 (GLP-1), growth hormone. The Global Pen Needles Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Pen Needles Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Pen Needles Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Global Pen Needles Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Novo Nordisk A/S, Becton, Dickinson and Company, TERUMO CORPORATION, Owen Mumford Ltd., Ypsomed, B. Braun Melsungen AG, HTL-STREFA, UltiMed, Inc., Allison Medical, Inc., and ArtsanaS.p.a. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Pen Needles Market has been segmented as below:
By Product Analysis:
By Length Analysis:
By Therapy Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Pen Needles Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Pen Needles Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Neurovascular Interventional Neurology Market
New Generation Implants Market
Newborn Screening Equipment Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Research Design
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study
3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion
4 Premium Insights
4.1 Market Overview
4.2 Geographic Analysis: Market, By Length
4.3 Market, By Type
4.4 Market, By Length
4.5 Market, By Mode of Purchase
4.6 Geographic Snapshot: Market
5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Favorable Reimbursement Environment and Government Support in Selected Countries
5.3.1.2 Advantages of Insulin Pens Over Syringes and Vials
5.3.1.3 Technological Advancements
5.3.1.4 Growing Diabetic Population
5.3.1.5 Conferences, Meetings, and Congresses to Create Pen Needle Awareness
5.3.2 Restraints
5.3.2.1 Poor Reimbursement Structure in Developing Countries
5.3.2.2 Needle Anxiety
5.3.2.3 Alternative Drug Delivery Methods
5.3.2.3.1 Oral Diabetic Agents and Oral Insulin
5.3.2.3.2 Inhalable Insulin
5.3.2.3.3 Nanotechnology to Aid in Transdermal and Inhalational Route of Administering Proteins and Peptides
5.3.2.4 Severe Shortage of Endocrinologists in the U.S.
5.3.2.5 Reuse of Pen Needles
5.3.3 Opportunities
5.3.3.1 Safety Needles
5.3.3.2 GLP-1 Analogues
5.3.4 Challenges
5.3.4.1 Minimizing the Reuse of Standard Pen Needles
5.3.4.2 Resistance Against Switching From Conventional Devices to Advanced Devices
6 Industry Insights
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat of New Entrants
6.2.2 Bargaining Power of Suppliers
6.2.3 Bargaining Power of Buyers
6.2.4 Segment Rivalry
6.2.5 Threat of Substitutes
6.3 Competitive Intensity
6.3.1 Evaluation Parameters
6.3.2 Scoring Methodology
6.3.3 Competitive Intensity Score, By Company
6.3.3.1 Competitive Intensity Score for BD
6.3.3.2 Competitive Intensity Score for Novo Nordisk
6.3.3.3 Competitive Intensity Score for Ypsomed
6.3.4 Competitive Intensity Mapping of BD, Novo Nordisk, and Ypsomed
6.3.5 Comparison of Evaluation Parameters, By Company
6.3.5.1 Pricing
6.3.5.2 Product Portfolio
6.3.5.3 Product Launches/Technological Advancements
6.3.5.4 Production Capacity (2015)
6.3.5.5 Geographical Presence
6.3.5.6 Promotional/Marketing Activities
6.3.5.7 Sponsorships/Donations/Education/Awareness Campaigns
6.3.5.8 M&As, Partnerships, Collaborations, Agreements, and Expansions
6.3.5.9 Years of Experience
6.3.5.10 Certifications/Accreditations/Awards
7 Pen Needles Market, By Type
7.1 Introduction
7.2 Standard Pen Needles
7.3 Safety Pen Needles
8 Pen Needles Market, By Needle Length
8.1 Introduction
8.2 4mm
8.3 5mm
8.4 6mm
8.5 8mm
8.6 10mm
8.7 12mm
9 Pen Needles Market, By Therapy
9.1 Introduction
9.2 Insulin
9.3 GLP-1
9.4 Growth Hormones
10 Pen Needles Market, By Mode of Purchase
10.1 Introduction
10.2 Retail
10.3 Non-Retail
11 Pen Needles Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.1.1 Growing Diabetes Prevalence and Favorable Reimbursement Scenario for Pen Needles
11.2.1.2 Federal Initiatives to Stimulate the U.S. Pen Needles Market
11.2.1.3 Focus of Leading Players on Increasing Market Penetration in the U.S.
11.2.1.4 Improvements in Pen Needle Technologies to Eliminate Needlestick Injuries
11.2.1.5 Low Penetration of Pen Injectors in the U.S. as Compared to Europe
11.2.2 Canada
11.2.2.1 High Diabetes Prevalence
11.2.2.2 Regulations for the Use of Safety-Engineered Needles
11.2.2.3 Government Support for Pen Needles in Alberta
11.3 Europe
11.3.1 Germany
11.3.1.1 Regulatory Framework to Minimize Needlestick Injuries & Boost Use of Safety-Engineered Devices
11.3.1.2 High Diabetes Prevalence and Reimbursement for Pen Needles
11.3.2 U.K.
11.3.2.1 Activities to Pool Funds for Diabetes Care & Research
11.3.3 France
11.3.3.1 Conferences and Exhibitions to Increase Exposure for Pen Needles Players in French Market
11.3.3.2 Higher Insurance Coverage and Increase in Aging Population and Affordability
11.3.4 Italy
11.3.4.1 Wide Regional Variations in Terms of Benefits and Coverage to Slow Growth in Italy
11.3.4.2 Awareness Campaigns for Diabetes in Italy to Propel the Market Growth
11.3.5 Spain
11.3.5.1 Large Pool of Diabetic Population, Regulations Mandating the Use of Safety Pen Needles
11.3.6 Rest of Europe
11.3.6.1 High Diabetes Prevalence in Russia, Poland, Romania, and Ukraine
11.4 Asia
11.4.1 Japan
11.4.1.1 High Adoption of Insulin Pens and Approval of Injectable Insulin
11.4.2 China
11.4.2.1 Growing Presence of Global and Local Players in China
11.4.2.2 High Diabetes Incidence and Adoption of Insulin Pens
11.4.2.3 High Reuse Rate & Lack of Reimbursement to Limit Market Growth
11.4.3 India
11.4.3.1 Growing Presence of Global Players in India
11.4.3.2 Low Pen Needle Penetration, Lack of Awareness to Restrain Market Growth
11.4.4 Rest of Asia
11.4.4.1 Vietnam, A Potential Market for Pen Needles
11.4.4.2 Increase in Pen Needles Likely in Singapore & Malaysia
11.5 Rest of the World (RoW)
11.5.1 Latin America
11.5.1.1 Increasing Diabetic Population and Rising Awareness on Diabetes in Brazil
11.5.2 Pacific Countries
11.5.2.1 Amendments in Ndss to Increase Access to Diabetic Products in Australia
11.5.2.2 Favorable Reimbursement Scenario and Presence of Charity Organizations in New Zealand
11.5.3 Middle East & Africa
11.5.3.1 Presence of Local & International Pen Needle Manufacturers and Rising Awareness on Pen Needles to Bolster the Market
11.5.3.2 Increasing Diabetic Population, Rising Awareness on Diabetes
12 Pen Needle Distributor List
13 Competitive Landscape
13.1 Overview
13.2 Market Share Analysis
13.2.1 Introduction
13.2.2 Becton, Dickinson & Co.
13.2.3 Novo Nordisk A/S
13.2.4 Ypsomed Holding AG
13.2.5 Others
13.3 Competitive Situation and Trends
13.3.1 Marketing and Promotion
13.3.2 Expansion
13.3.3 Product Launch
13.3.4 Others
14 Company Profiles
14.1 Introduction
14.2 Becton, Dickinson and Company
14.3 Novo Nordisk A/S
14.4 Ypsomed Holding AG
14.5 Owen Mumford, Ltd.
14.6 HTL-Strefa S.A.
14.7 B. Braun Melsungen
14.8 Terumo Corporation
14.9 Ultimed, Inc. (LDI, Ltd.)
14.10 Allison Medical, Inc.
14.11 Artsana S.P.A.
The Global Pen Needles Market has been segmented as below:
By Product Analysis:
By Length Analysis:
By Therapy Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
